Zomato-3-Short term Sell-Mid term long
Updated
Zomato CMP:174.20; RSI: 66.50;
Short Term View: Zomato has completed 5th wave and entered in ABC pattern correction. This short term momentum will fizzle out in 1 week time frame, before that the script may show price of 181-182 levels, and eneter in wave-C correction phase.
Mid Term View: Script will break down and fall below Rs: 158 in months time. Accumulate the script between 156 to 144 levels. for next round of upmove to a level of 188- 199-220.
Disclaimer: This written/visual material is comprised of personal opinions and ideas. The content should not be construed as containing any type of investment advice and/or a solicitation for any transactions. It does not imply an obligation to purchase investment services, nor does it guarantee or predict future performance
Short Term View: Zomato has completed 5th wave and entered in ABC pattern correction. This short term momentum will fizzle out in 1 week time frame, before that the script may show price of 181-182 levels, and eneter in wave-C correction phase.
Mid Term View: Script will break down and fall below Rs: 158 in months time. Accumulate the script between 156 to 144 levels. for next round of upmove to a level of 188- 199-220.
Disclaimer: This written/visual material is comprised of personal opinions and ideas. The content should not be construed as containing any type of investment advice and/or a solicitation for any transactions. It does not imply an obligation to purchase investment services, nor does it guarantee or predict future performance
Trade active
Wave B bounce back was strong and took the script to breach the Mid Term Target of 199; avg monthly Volumes are constant. As the script is in corrective wave pattern a sudden reversal in setiment will take the script tumbling below 170 odd levels. should keep the strickt stop loss 178;
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.